FDA Antiviral Advisory Committee Meetings

The Antiviral Drugs Advisory Committee has four AIDS-related meetings in the next month; all are open to the public, and public testimony will be taken. Note that some information about the locations which was published in the FEDERAL REGISTER on January 31 is erroneous.

February 28, 8:30-5:00: Recent studies with nucleoside analogs (ACTG 175, the Delta study, and others), and how the results should affect standard of care.

February 29, 8:30-5:00: Ritonavir (Abbott Laboratories protease inhibitor).

March 1, 8:30-5:00: Crixivan(R) (Merck & Co. protease inhibitor).

March 1 also, 8:00-5:00: A joint meeting of the Antiviral Drugs Advisory Committee and the Endocrine and Metabolic Drugs Advisory Committee, on Serostim(TM) (human growth hormone) to treat AIDS-related wasting. (This meeting will be at the Holiday Inn, Silver Spring, Maryland; the other three meetings will be at the Holiday Inn, Gaithersburg, Maryland. The Antiviral Drugs Advisory Committee will be divided for the two simultaneous March 1 meetings.)

For the most current information, call the FDA Advisory Committee Hotline, 800/741-8138. When it asks for a 5-digit code, enter the code for the Antiviral Drugs Advisory Committee, 12531.